Mehrotra, Megha L.
Glidden, David V.
McMahan, Vanessa
Amico, K. Rivet
Hosek, Sybil
Defechereux, Patricia
Mayer, Kenneth H.
Veloso, Valdilea G.
Bekker, Linda-Gail
Avelino-Silva, Vivian I.
Schechter, Mauro
Grant, Robert M.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (5U01AI064002)
Article History
First Online: 28 April 2016
Compliance with Ethical Standards
:
: DVG has received fees from ViiV, a manufacturer of an investigational compound being investigated for use as PrEP. RA has an educational grant from Gilead Sciences through the University of Michigan. KM has received unrestricted research and education grants from Gilead Sciences. RMG has received honoraria from Clinical Care Options. RMG served as a consultant for Siemens Healthcare on their guidelines panel. The remaining authors have no conflicts of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.